BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y, Qian Y, Huang Q, Ni Q, Liu C, Yu X. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter. Biochim Biophys Acta Rev Cancer 2021;1875:188409. [PMID: 32827580 DOI: 10.1016/j.bbcan.2020.188409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Cao Y, Zhao R, Guo K, Ren S, Zhang Y, Lu Z, Tian L, Li T, Chen X, Wang Z. Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma. Front Oncol 2022;11:744667. [DOI: 10.3389/fonc.2021.744667] [Reference Citation Analysis]
2 Liu Q, Zhao G, Zhang X, Jiang N, Zhao Z, Wang Y, Xu S, Zhu L, Lau WY, Dai G, Liu R. Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases: a retrospective cohort study. Langenbecks Arch Surg 2021. [PMID: 34518900 DOI: 10.1007/s00423-021-02321-7] [Reference Citation Analysis]
3 Arias-Pinilla GA, Modjtahedi H. Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities. Cancers (Basel) 2021;13:1781. [PMID: 33917882 DOI: 10.3390/cancers13081781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xie X, Ji J, Chen X, Xu W, Chen H, Zhu S, Wu J, Wu Y, Sun Y, Sai W, Liu Z, Xiao M, Bao B. Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-3. Clin Transl Oncol 2021. [PMID: 34811696 DOI: 10.1007/s12094-021-02705-7] [Reference Citation Analysis]
5 Bai M, Wang S, Liang G, Cai Y, Lu Y, Hou N, Ma R, Xu H, Zhang M. Nomogram to Predict Incomplete Cytoreduction for Pseudomyxoma Peritonei. Ann Surg Oncol 2021. [PMID: 34480280 DOI: 10.1245/s10434-021-10725-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Song Q, Shi Y, Gao F, Meng Y, Yang R, Liu Y, Zhong S, Hong Y. Feasibility and Reproducibility of Multifrequency Magnetic Resonance Elastography in Healthy and Diseased Pancreases. J Magn Reson Imaging 2022. [PMID: 35332973 DOI: 10.1002/jmri.28158] [Reference Citation Analysis]
7 Watanabe K, Nakamura Y, Low SK. Clinical implementation and current advancement of blood liquid biopsy in cancer. J Hum Genet 2021;66:909-26. [PMID: 34088974 DOI: 10.1038/s10038-021-00939-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Xiao J, He X. Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:8781-94. [PMID: 34849030 DOI: 10.2147/CMAR.S336265] [Reference Citation Analysis]
9 Imamura T, Okamura Y, Sugiura T, Yamamoto Y, Ito T, Ashida R, Ohgi K, Ohtsuka S, Uesaka K. ASO Author Reflections: Albumin-Bilirubin Grade is an Independent Prognostic Factor Complementary to CA19-9 for Pancreatic Cancer Patients. Ann Surg Oncol 2021. [PMID: 33586063 DOI: 10.1245/s10434-021-09660-1] [Reference Citation Analysis]
10 Aita A, Millino C, Sperti C, Pacchioni B, Plebani M, Pittà C, Basso D. Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study. Biomedicines 2021;9:845. [PMID: 34356909 DOI: 10.3390/biomedicines9070845] [Reference Citation Analysis]
11 Hong L, Xu L, Jin L, Xu K, Tang W, Zhu Y, Qiu X, Wang J. Exosomal circular RNA hsa_circ_0006220, and hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic cancer. J Clin Lab Anal 2022;:e24447. [PMID: 35446993 DOI: 10.1002/jcla.24447] [Reference Citation Analysis]
12 Li X, Fan Y, Zhang Y, Wang Y, Zhao M, Tang M, Li H, Mi J, Geng Z, Wang Z, Su F. CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma. Front Genet 2022;13:876588. [DOI: 10.3389/fgene.2022.876588] [Reference Citation Analysis]
13 Masuda H, Kotecha K, Maitra R, Gill AJ, Mittal A, Samra JS. Clinical suspicion of pancreatic cancer despite negative endoscopic ultrasound-guided fine-needle aspiration biopsy. ANZ J Surg 2021. [PMID: 34636123 DOI: 10.1111/ans.17256] [Reference Citation Analysis]
14 Oba A, Del Chiaro M, Satoi S, Kim SW, Takahashi H, Yu J, Hioki M, Tanaka M, Kato Y, Ariake K, Wu YHA, Inoue Y, Takahashi Y, Hackert T, Wolfgang CL, Besselink MG, Schulick RD, Nagakawa Y, Isaji S, Tsuchida A, Endo I. New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS). J Hepatobiliary Pancreat Sci 2021. [PMID: 34581016 DOI: 10.1002/jhbp.1049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wu Y, Gu Y, Zhang B, Zhou X, Li Y, Qian Z. Laparoscopic ultrasonography-guided cryoablation of locally advanced pancreatic cancer: a preliminary report. Jpn J Radiol 2021. [PMID: 34279799 DOI: 10.1007/s11604-021-01175-9] [Reference Citation Analysis]
16 Yang J, Xu R, Wang C, Qiu J, Ren B, You L. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun (Lond) 2021. [PMID: 34331845 DOI: 10.1002/cac2.12204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Feng Z, Li K, Wu Y, Peng C. Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Front Mol Biosci 2021;8:659168. [PMID: 33834039 DOI: 10.3389/fmolb.2021.659168] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Pan S, Chen R. Pathological implication of protein post-translational modifications in cancer. Molecular Aspects of Medicine 2022. [DOI: 10.1016/j.mam.2022.101097] [Reference Citation Analysis]
19 Yang Y, Ding Y, Gong Y, Zhao S, Li M, Li X, Song G, Zhai B, Liu J, Shao Y, Zhu L, Pang J, Ma Y, Ou Q, Wu X, Zhang Z. The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification. BMC Cancer 2022;22:186. [PMID: 35180847 DOI: 10.1186/s12885-022-09279-9] [Reference Citation Analysis]